509 related articles for article (PubMed ID: 31101936)
1. Antiviral peptides as promising therapeutic drugs.
Vilas Boas LCP; Campos ML; Berlanda RLA; de Carvalho Neves N; Franco OL
Cell Mol Life Sci; 2019 Sep; 76(18):3525-3542. PubMed ID: 31101936
[TBL] [Abstract][Full Text] [Related]
2. Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.
Ashaolu TJ; Nawaz A; Walayat N; Khalifa I
Appl Microbiol Biotechnol; 2021 May; 105(9):3457-3470. PubMed ID: 33876282
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs).
Fu Y; Jaarsma AH; Kuipers OP
Cell Mol Life Sci; 2021 Apr; 78(8):3921-3940. PubMed ID: 33532865
[TBL] [Abstract][Full Text] [Related]
4. [Antiviral activity of extracts of basidiomycetes and humic compounds substances against Human Immunodeficiency Virus (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus 1) and Herpes Simplex Virus (Herpesviridae: Simplexvirus: Human alphaherpesvirus 1)].
Nosik DN; Nosik NN; Teplyakova TV; Lobach OA; Kiseleva IA; Kondrashina NG; Bochkova MS; Ananko GG
Vopr Virusol; 2020 Nov; 65(5):276-283. PubMed ID: 33533211
[TBL] [Abstract][Full Text] [Related]
5. Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.
Zannella C; Chianese A; Palomba L; Marcocci ME; Bellavita R; Merlino F; Grieco P; Folliero V; De Filippis A; Mangoni M; Nencioni L; Franci G; Galdiero M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216177
[TBL] [Abstract][Full Text] [Related]
6. Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses.
Hollmann A; Cardoso NP; Espeche JC; Maffía PC
Peptides; 2021 Aug; 142():170570. PubMed ID: 34000327
[TBL] [Abstract][Full Text] [Related]
7. Identification of natural antimicrobial peptides mimetic to inhibit Ca
Asseri AH; Islam MR; Alghamdi RM; Altayb HN
J Bioenerg Biomembr; 2024 Apr; 56(2):125-139. PubMed ID: 38095733
[TBL] [Abstract][Full Text] [Related]
8. Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide.
Rothan HA; Mohamed Z; Suhaeb AM; Rahman NA; Yusof R
OMICS; 2013 Nov; 17(11):560-7. PubMed ID: 24044366
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses.
van de Sand L; Bormann M; Schmitz Y; Heilingloh CS; Witzke O; Krawczyk A
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372592
[TBL] [Abstract][Full Text] [Related]
10. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H
Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Cyanometabolites-A Review.
Mazur-Marzec H; Cegłowska M; Konkel R; Pyrć K
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33810129
[TBL] [Abstract][Full Text] [Related]
12. Scorpion-Derived Antiviral Peptides with a Special Focus on Medically Important Viruses: An Update.
El Hidan MA; Laaradia MA; El Hiba O; Draoui A; Aimrane A; Kahime K
Biomed Res Int; 2021; 2021():9998420. PubMed ID: 34527748
[TBL] [Abstract][Full Text] [Related]
13. The antimicrobial peptide HS-1 inhibits dengue virus infection.
Monteiro JMC; Oliveira MD; Dias RS; Nacif-Marçal L; Feio RN; Ferreira SO; Oliveira LL; Silva CC; Paula SO
Virology; 2018 Jan; 514():79-87. PubMed ID: 29153860
[TBL] [Abstract][Full Text] [Related]
14. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.
Sukmarini L
Molecules; 2022 Apr; 27(9):. PubMed ID: 35565968
[TBL] [Abstract][Full Text] [Related]
15. New advances in anti-HSV chemotherapy.
Superti F; Ammendolia MG; Marchetti M
Curr Med Chem; 2008; 15(9):900-11. PubMed ID: 18473797
[TBL] [Abstract][Full Text] [Related]
16. Antiviral peptides against Coronaviridae family: A review.
Heydari H; Golmohammadi R; Mirnejad R; Tebyanian H; Fasihi-Ramandi M; Moosazadeh Moghaddam M
Peptides; 2021 May; 139():170526. PubMed ID: 33676968
[TBL] [Abstract][Full Text] [Related]
17. Insects antiviral and anticancer peptides: new leads for the future?
Slocinska M; Marciniak P; Rosinski G
Protein Pept Lett; 2008; 15(6):578-85. PubMed ID: 18680452
[TBL] [Abstract][Full Text] [Related]
18. The Development of Peptide-based Antimicrobial Agents against Dengue Virus.
Huang YW; Lee CT; Wang TC; Kao YC; Yang CH; Lin YM; Huang KS
Curr Protein Pept Sci; 2018; 19(10):998-1010. PubMed ID: 29852867
[TBL] [Abstract][Full Text] [Related]
19. Linear antimicrobial peptides with activity against herpes simplex virus 1 and Aichi virus.
Vilas Boas LC; de Lima LM; Migliolo L; Mendes GD; de Jesus MG; Franco OL; Silva PA
Biopolymers; 2017 Mar; 108(2):. PubMed ID: 27161201
[TBL] [Abstract][Full Text] [Related]
20. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
